Nogra Group Sicaf Sif Gg Strategic - Net Worth and Insider Trading

Nogra Group Sicaf Sif Gg Strategic Net Worth

The estimated net worth of Nogra Group Sicaf Sif Gg Strategic is at least $600 Million dollars as of 2024-04-27. Nogra Group Sicaf Sif Gg Strategic is the 10% Owner of Royalty Pharma PLC and owns about 21,426,170 shares of Royalty Pharma PLC (RPRX) stock worth over $600 Million. Details can be seen in Nogra Group Sicaf Sif Gg Strategic's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nogra Group Sicaf Sif Gg Strategic has not made any transactions after 2022-09-20 and currently still holds the listed stock(s).

Transaction Summary of Nogra Group Sicaf Sif Gg Strategic

Nogra Group Sicaf Sif Gg Strategic Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nogra Group Sicaf Sif Gg Strategic owns 1 companies in total, including Royalty Pharma PLC (RPRX) .

Click here to see the complete history of Nogra Group Sicaf Sif Gg Strategic’s form 4 insider trades.

Insider Ownership Summary of Nogra Group Sicaf Sif Gg Strategic

Ticker	Comapny	Transaction Date	Type of Owner
RPRX	Royalty Pharma PLC	2022-09-20	10 percent owner

Nogra Group Sicaf Sif Gg Strategic Latest Holdings Summary

Nogra Group Sicaf Sif Gg Strategic currently owns a total of 1 stock. Nogra Group Sicaf Sif Gg Strategic owns 21,426,170 shares of Royalty Pharma PLC (RPRX) as of September 20, 2022, with a value of $600 Million.

Latest Holdings of Nogra Group Sicaf Sif Gg Strategic

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
RPRX	Royalty Pharma PLC	2022-09-20	21,426,170	28.00	599,932,760

Holding Weightings of Nogra Group Sicaf Sif Gg Strategic

Nogra Group Sicaf Sif Gg Strategic Form 4 Trading Tracker

According to the SEC Form 4 filings, Nogra Group Sicaf Sif Gg Strategic has made a total of 4 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Royalty Pharma PLC is the sale of 267,815 shares on September 20, 2022, which brought Nogra Group Sicaf Sif Gg Strategic around $11 Million.

Insider Trading History of Nogra Group Sicaf Sif Gg Strategic

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nogra Group Sicaf Sif Gg Strategic Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nogra Group Sicaf Sif Gg Strategic Ownership Network

Ownership Network List of Nogra Group Sicaf Sif Gg Strategic

No Data

Ownership Network Relation of Nogra Group Sicaf Sif Gg Strategic

Nogra Group Sicaf Sif Gg Strategic Owned Company Details

What does Royalty Pharma PLC do?

Who are the key executives at Royalty Pharma PLC?

Nogra Group Sicaf Sif Gg Strategic is the 10 percent owner of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .

Royalty Pharma PLC (RPRX) Insider Trades Summary

Over the past 18 months, Nogra Group Sicaf Sif Gg Strategic made no insider transaction in Royalty Pharma PLC (RPRX). Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net sale of 420,000 shares made by George W. Lloyd , a net sale of 2,479,950 shares made by Rory B Riggs , and a net purchase of 600,000 shares made by Pablo G. Legorreta .

In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,484,548 shares of Royalty Pharma PLC (RPRX) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 3,884,548 shares.

Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Royalty Pharma PLC Insider Transactions

No Available Data

Nogra Group Sicaf Sif Gg Strategic Mailing Address

Above is the net worth, insider trading, and ownership report for Nogra Group Sicaf Sif Gg Strategic. You might contact Nogra Group Sicaf Sif Gg Strategic via mailing address: C/o Nogra Group Sicaf-sif S.a., 18 Avenue De La Porte Neuve, Luxembourg N4 L-2227.

Discussions on Nogra Group Sicaf Sif Gg Strategic

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.